Industry news
GSK pays fines in US for illegal promotion
GlaxoSmithKline has agreed to a $105 million settlement in the USA regarding alleged unlawful promotion of Chronic Obstructive Pulmonary Disease and Asthma blockbuster Advair and the antidepressants Paxil and Wellbutrin.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.